Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

Alex Wilkes Is Appointed President, Americas of CooperVision

Alex Wilkes appointment becomes effective June 14.

Alex Wilkes brings more than a decade of experience in the eye care industry, having most recently served as Senior Vice President and General Manager of Pearle Vision at Luxottica.

At CooperVision, Wilkes will be responsible for the executive leadership and driving the growth of the company’s largest region, determining the strategic direction for the United States, Canada, and Latin America.

“In the years Alex has spent in vision care, he has led the expansion of one of the largest franchises in the industry, working directly with eye care professionals to build their businesses while playing a key role in branding, marketing, operations, product strategy, and supply chain management,” said Mark Harty, Executive Vice President and Chief Commercial Officer, CooperVision. “Alex’s proven track record of driving growth, developing market-shifting strategies, and leading high-performing teams is sure to benefit CooperVision and our customers in the years ahead.”

“The current pace of change in the optical category is unprecedented, and I’m thrilled to join the talented team at CooperVision to deliver some of the most innovative products in the market to eye care professionals and their patients,” said Wilkes. “I have admired CooperVision for many years and I am completely aligned with the values and direction of the company.”

Wilkes joined Luxottica in 2010 as Senior Director of Strategy and Business Development, where he was responsible for the strategic planning and implementation of several growth initiatives for LensCrafters. In 2012, he was promoted to the Vice President of Vision Care for LensCrafters. As part of the executive leadership team, he had responsibility for 3,000 eye care professionals, all clinical services, and the company’s contact lens portfolio.

Prior to that, Wilkes was a management consultant at Accenture for more than five years, with a focus on the consumer products, retail, and telecommunications industries. Earlier in his career, he was a consultant at Deloitte. Wilkes earned his bachelor’s degree from the University of Iowa. He will be based at CooperVision’s offices in Victor, N.Y.

Wilkes succeeds Jerry Warner, who was promoted to President of CooperVision in February 2022.


Other executives on the move and in the news can be found here.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

MORE EXECUTIVES

Broken String Biosciences Strengthens Senior Leadership Team

Bringing significant expertise in their respective fields, Vincent Smith, PhD and Jessica Rich appointments are a key part of Broken String’s strategy to deliver on its Series A goals, which include the continued development of its INDUCE-seq™ DNA break-mapping platform and acceleration of its commercial expansion across global markets.

New Chief Sales Officer at Encare with Focus on Continued Global Expansion

The HealthTech company Encare has recruited Lotta Sellén as the new Chief Sales Officer (CSO). Lotta Sellén has solid experience in the pharmaceutical, healthcare and HealthTech industries.

CorWave Appoints Magalie Durrèche as Chief Financial Officer

Magalie Durrèche will oversee the financial management and participate in the strategic planning and fundraising of CorWave, a company developing and manufacturing a blood pump based on breakthrough technology. She succeeds Zina Hamoumi, who served as Chief Financial Officer for five years before deciding to focus on other projects.

Veracyte Names Dr Phillip G Febbo Chief Scientific Officer and Chief Medical Officer

“Phil G Febbo is an exceptional leader with a strong track record of driving successful commercialization of molecular tests through evidence development, guideline inclusion and key opinion leader support,” said Mr. Stapley. “His experience and expertise will be critical to further enhancing our ability to serve our customers and, ultimately, to transforming cancer care for patients all over the world.”

GrayMatters Health Expands US Executive Team, Including Appointment of Dr Aron Tendler as Chief Medical Office

Dr Aaron Tendler is a board-certified psychiatrist based in Palm Beach, Florida, bringing over 20 years of experience as an industry leader researching novel treatments for mental health disorders.

By using this website you agree to accept Medical Device News Magazine Privacy Policy